Morgan Stanley’s Bioceres Crop Solutions BIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $285K | Sell |
63,789
-31,862
| -33% | -$142K | ﹤0.01% | 5709 |
|
|
2025
Q1 | $437K | Sell |
95,651
-14,134
| -13% | -$64.5K | ﹤0.01% | 5392 |
|
|
2024
Q4 | $667K | Buy |
109,785
+40,136
| +58% | +$244K | ﹤0.01% | 5298 |
|
|
2024
Q3 | $548K | Hold |
69,649
| – | – | ﹤0.01% | 5360 |
|
|
2024
Q2 | $781K | Sell |
69,649
-39,535
| -36% | -$443K | ﹤0.01% | 5103 |
|
|
2024
Q1 | $1.38M | Buy |
109,184
+34,250
| +46% | +$434K | ﹤0.01% | 4793 |
|
|
2023
Q4 | $1.03M | Buy |
74,934
+72,768
| +3,360% | +$999K | ﹤0.01% | 5277 |
|
|
2023
Q3 | $24.5K | Sell |
2,166
-534
| -20% | -$6.03K | ﹤0.01% | 6424 |
|
|
2023
Q2 | $36.1K | Sell |
2,700
-10,063
| -79% | -$134K | ﹤0.01% | 6343 |
|
|
2023
Q1 | $148K | Sell |
12,763
-1,720
| -12% | -$20K | ﹤0.01% | 5842 |
|
|
2022
Q4 | $174K | Sell |
14,483
-1,072
| -7% | -$12.9K | ﹤0.01% | 5722 |
|
|
2022
Q3 | $202K | Buy |
15,555
+5,331
| +52% | +$69.2K | ﹤0.01% | 5724 |
|
|
2022
Q2 | $140K | Sell |
10,224
-2,395
| -19% | -$32.8K | ﹤0.01% | 6089 |
|
|
2022
Q1 | $172K | Buy |
12,619
+2,500
| +25% | +$34.1K | ﹤0.01% | 6000 |
|
|
2021
Q4 | $143K | Buy |
10,119
+2,500
| +33% | +$35.3K | ﹤0.01% | 6243 |
|
|
2021
Q3 | $103K | Sell |
7,619
-893
| -10% | -$12.1K | ﹤0.01% | 6355 |
|
|
2021
Q2 | $120K | Buy |
8,512
+893
| +12% | +$12.6K | ﹤0.01% | 6270 |
|
|
2021
Q1 | $78K | Sell |
7,619
-1,109
| -13% | -$11.4K | ﹤0.01% | 6139 |
|
|
2020
Q4 | $54K | Sell |
8,728
-891
| -9% | -$5.51K | ﹤0.01% | 6140 |
|
|
2020
Q3 | $52K | Buy |
+9,619
| New | +$52K | ﹤0.01% | 5709 |
|